Please provide your email address to receive an email when new articles are posted on . Intraosseous vancomycin levels were minimally detected at the end of the procedure vs. IV vancomycin levels.

Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Greater focus on designing automated intraosseous infusion devices is expected to offer lucrative growth opportunities for players in the global ...

CHICAGO — Low-dose intraosseous regional administration of vancomycin in patients undergoing primary total knee arthroplasty produced four to five times the antibiotic concentration in subcutaneous ...

Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 ...

New York, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intraosseous Infusion Devices Industry" - https://www ...

Future Market Insights delivers key insights on the global Intraosseous Infusion Devices market in a new publication titled “Intraosseous Infusion Devices Market: Global Industry Analysis & ...

According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Intraosseous Infusion Devices Market: Global Industry Analysis & Opportunity Assessment, 2016-2026" report to their ...